JOHNSON & JOHNSON — Director's Dealing 2021

Feb 18, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2021-02-12

Reporting Person: McEvoy Ashley (EVP, WW Chair, Medical Devices)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-12	Common Stock	M	11034.0000	—	Acquired	32731.9545	Direct
2021-02-12	Common Stock	M	2102.0000	—	Acquired	34833.9545	Direct
2021-02-12	Common Stock	F	588.0000	$165.5500	Disposed	34245.9545	Direct
2021-02-12	Common Stock	F	4090.0000	$165.5500	Disposed	30155.9545	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-12	Performance Share Units	$	M	11034.0000	Disposed		Common Stock (11034.0000)	Direct
2021-02-12	Restricted Share Units	$	M	2102.0000	Disposed		Common Stock (2102.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2495.0000	Indirect
Common Stock	300.0000	Indirect

Footnotes

F1: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting.

F2: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting.

F3: Shares withheld for payment of taxes upon vesting of Restricted Share Units.

F4: Shares withheld for payment of taxes upon vesting of Performance Share Units.

F5: Shares held in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2021).

F6: Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2021).